The Asia Pacific Motion Sickness Treatment Market would witness market growth of 3.9% CAGR during the forecast period (2023-2029).
The market should expand as a result of the growing demand for medications that may successfully alleviate the symptoms of motion sickness. This condition is a typical hazard that is connected with extensive foreign travel. In addition, research has found that there is a gender difference in the frequency of motion sickness symptoms in virtual reality (VR), with females experiencing more symptoms than males do. This is because females tend to be more sensitive to motion sickness than males.
The considerable prevalence of motion sickness, particularly among females, is the reason for the projected rise in the demand for anticholinergic and antihistamines medications that inhibit emetic H1-receptors from preventing motion sickness. This is due to the fact that these treatments prevent emetic H1-receptors from activating. Because of this, it is anticipated that the growth of the market will accelerate throughout the time in question.
Moreover, the increasing emphasis of the enterprise on introducing merchandise that addresses and minimizes motion sickness indications is also bolstering market expansion. Introducing a cutting-edge waterproof wearable therapeutic device that provides user-controlled therapy for a range of nausea and vomiting conditions, including those caused by doctor-diagnosed migraines, morning sickness from alcohol withdrawal, anxiety, pregnancy, motion sickness, chemotherapy, and post-operative nausea.
India boasts many natural, historical, cultural, and spiritual treasures. India's spiritual grandeur and heritage attract millions of local and foreign tourists who seek to experience them. Links to sacred or historic locations, people, or events have been instrumental in the growth of several popular tourist destinations, with religion, spirituality, and legacy being significant motivators for travel.
To fully realize the potential of pilgrimage and heritage tourism in India, authorities are striving to integrate development plans for the chosen pilgrimage destinations and heritage cities in collaboration with other stakeholders. Due to these factors, the travel industry in the APAC region is expected to experience growth, and with the rise in tourism, people suffering from motion sickness are expected to increase, which will provide market growth for motion sickness treatment in the region.
The China market dominated the Asia Pacific Motion Sickness Treatment Market by Country in 2022; thereby, achieving a market value of $37.4 Million by 2029. The Japan market is poised to grow at a CAGR of 3.3% during (2023 - 2029). Additionally, The India market would showcase a CAGR of 4.6% during (2023 - 2029).
Based on Drug Class, the market is segmented into Antihistamines, Anticholinergics and Others. Based on Route of Administration, the market is segmented into Oral and Others. Based on Distribution Channel, the market is segmented into Drug Store & Retail Pharmacies, Hospital Pharmacies and Online Pharmacies. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Motion Sickness Treatment Market is Projected to reach USD 481 Million by 2029, at a CAGR of 3.2%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Viatris, Inc., Teva Pharmaceutical Industries Ltd., Amneal Pharmaceuticals, Inc., Baxter International, Inc., Novartis AG, Abbott Laboratories, Sun Pharmaceutical Industries Ltd., Zydus Lifesciences Ltd., Prestige Consumer Healthcare, Inc., WellSpring Pharmaceutical Corporation (Avista Capital Partners).
Scope of the Study
Market Segments Covered in the Report:
By Drug Class
- Antihistamines
- Anticholinergics
- Others
By Route of Administration
By Distribution Channel
- Drug Store & Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Viatris, Inc.
- Teva Pharmaceutical Industries Ltd.
- Amneal Pharmaceuticals, Inc.
- Baxter International, Inc.
- Novartis AG
- Abbott Laboratories
- Sun Pharmaceutical Industries Ltd.
- Zydus Lifesciences Ltd.
- Prestige Consumer Healthcare, Inc.
- WellSpring Pharmaceutical Corporation (Avista Capital Partners)
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Motion Sickness Treatment Market, by Drug Class
1.4.2 Asia Pacific Motion Sickness Treatment Market, by Route of Administration
1.4.3 Asia Pacific Motion Sickness Treatment Market, by Distribution Channel
1.4.4 Asia Pacific Motion Sickness Treatment Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Asia Pacific Motion Sickness Treatment Market by Drug Class
3.1 Asia Pacific Antihistamines Market by Country
3.2 Asia Pacific Anticholinergics Market by Country
3.3 Asia Pacific Others Market by Country
Chapter 4. Asia Pacific Motion Sickness Treatment Market by Route of Administration
4.1 Asia Pacific Oral Market by Country
4.2 Asia Pacific Others Market by Country
Chapter 5. Asia Pacific Motion Sickness Treatment Market by Distribution Channel
5.1 Asia Pacific Drug Store & Retail Pharmacies Market by Country
5.2 Asia Pacific Hospital Pharmacies Market by Country
5.3 Asia Pacific Online Pharmacies Market by Country
Chapter 6. Asia Pacific Motion Sickness Treatment Market by Country
6.1 China Motion Sickness Treatment Market
6.1.1 China Motion Sickness Treatment Market by Drug Class
6.1.2 China Motion Sickness Treatment Market by Route of Administration
6.1.3 China Motion Sickness Treatment Market by Distribution Channel
6.2 Japan Motion Sickness Treatment Market
6.2.1 Japan Motion Sickness Treatment Market by Drug Class
6.2.2 Japan Motion Sickness Treatment Market by Route of Administration
6.2.3 Japan Motion Sickness Treatment Market by Distribution Channel
6.3 India Motion Sickness Treatment Market
6.3.1 India Motion Sickness Treatment Market by Drug Class
6.3.2 India Motion Sickness Treatment Market by Route of Administration
6.3.3 India Motion Sickness Treatment Market by Distribution Channel
6.4 South Korea Motion Sickness Treatment Market
6.4.1 South Korea Motion Sickness Treatment Market by Drug Class
6.4.2 South Korea Motion Sickness Treatment Market by Route of Administration
6.4.3 South Korea Motion Sickness Treatment Market by Distribution Channel
6.5 Singapore Motion Sickness Treatment Market
6.5.1 Singapore Motion Sickness Treatment Market by Drug Class
6.5.2 Singapore Motion Sickness Treatment Market by Route of Administration
6.5.3 Singapore Motion Sickness Treatment Market by Distribution Channel
6.6 Malaysia Motion Sickness Treatment Market
6.6.1 Malaysia Motion Sickness Treatment Market by Drug Class
6.6.2 Malaysia Motion Sickness Treatment Market by Route of Administration
6.6.3 Malaysia Motion Sickness Treatment Market by Distribution Channel
6.7 Rest of Asia Pacific Motion Sickness Treatment Market
6.7.1 Rest of Asia Pacific Motion Sickness Treatment Market by Drug Class
6.7.2 Rest of Asia Pacific Motion Sickness Treatment Market by Route of Administration
6.7.3 Rest of Asia Pacific Motion Sickness Treatment Market by Distribution Channel
Chapter 7. Company Profiles
7.1 Viatris, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental Analysis
7.1.4 Research & Development Expense
7.2 Teva Pharmaceutical Industries Ltd.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expenses
7.3 Amneal Pharmaceuticals, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental Analysis
7.3.4 Research & Development Expenses
7.4 Baxter International, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental Analysis
7.4.4 Research & Development Expense
7.5 Novartis AG
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.6 Abbott Laboratories
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.6.5 SWOT Analysis
7.7 Sun Pharmaceutical Industries Ltd.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expenses
7.8 Zydus Lifesciences Ltd.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Trials and Approvals:
7.9 Prestige Consumer Healthcare, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.10. WellSpring Pharmaceutical Corporation (Avista Capital Partners)
7.10.1 Company Overview
TABLE 1 Asia Pacific Motion Sickness Treatment Market, 2019 - 2022, USD Million
TABLE 2 Asia Pacific Motion Sickness Treatment Market, 2023 - 2029, USD Million
TABLE 3 Asia Pacific Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 4 Asia Pacific Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
TABLE 5 Asia Pacific Antihistamines Market by Country, 2019 - 2022, USD Million
TABLE 6 Asia Pacific Antihistamines Market by Country, 2023 - 2029, USD Million
TABLE 7 Asia Pacific Anticholinergics Market by Country, 2019 - 2022, USD Million
TABLE 8 Asia Pacific Anticholinergics Market by Country, 2023 - 2029, USD Million
TABLE 9 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 10 Asia Pacific Others Market by Country, 2023 - 2029, USD Million
TABLE 11 Asia Pacific Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
TABLE 12 Asia Pacific Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
TABLE 13 Asia Pacific Oral Market by Country, 2019 - 2022, USD Million
TABLE 14 Asia Pacific Oral Market by Country, 2023 - 2029, USD Million
TABLE 15 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 16 Asia Pacific Others Market by Country, 2023 - 2029, USD Million
TABLE 17 Asia Pacific Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 18 Asia Pacific Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 19 Asia Pacific Drug Store & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 20 Asia Pacific Drug Store & Retail Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 21 Asia Pacific Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 22 Asia Pacific Hospital Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 23 Asia Pacific Online Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 24 Asia Pacific Online Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 25 Asia Pacific Motion Sickness Treatment Market by Country, 2019 - 2022, USD Million
TABLE 26 Asia Pacific Motion Sickness Treatment Market by Country, 2023 - 2029, USD Million
TABLE 27 China Motion Sickness Treatment Market, 2019 - 2022, USD Million
TABLE 28 China Motion Sickness Treatment Market, 2023 - 2029, USD Million
TABLE 29 China Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 30 China Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
TABLE 31 China Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
TABLE 32 China Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
TABLE 33 China Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 34 China Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 35 Japan Motion Sickness Treatment Market, 2019 - 2022, USD Million
TABLE 36 Japan Motion Sickness Treatment Market, 2023 - 2029, USD Million
TABLE 37 Japan Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 38 Japan Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
TABLE 39 Japan Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
TABLE 40 Japan Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
TABLE 41 Japan Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 42 Japan Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 43 India Motion Sickness Treatment Market, 2019 - 2022, USD Million
TABLE 44 India Motion Sickness Treatment Market, 2023 - 2029, USD Million
TABLE 45 India Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 46 India Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
TABLE 47 India Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
TABLE 48 India Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
TABLE 49 India Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 50 India Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 51 South Korea Motion Sickness Treatment Market, 2019 - 2022, USD Million
TABLE 52 South Korea Motion Sickness Treatment Market, 2023 - 2029, USD Million
TABLE 53 South Korea Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 54 South Korea Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
TABLE 55 South Korea Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
TABLE 56 South Korea Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
TABLE 57 South Korea Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 58 South Korea Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 59 Singapore Motion Sickness Treatment Market, 2019 - 2022, USD Million
TABLE 60 Singapore Motion Sickness Treatment Market, 2023 - 2029, USD Million
TABLE 61 Singapore Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 62 Singapore Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
TABLE 63 Singapore Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
TABLE 64 Singapore Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
TABLE 65 Singapore Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 66 Singapore Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 67 Malaysia Motion Sickness Treatment Market, 2019 - 2022, USD Million
TABLE 68 Malaysia Motion Sickness Treatment Market, 2023 - 2029, USD Million
TABLE 69 Malaysia Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 70 Malaysia Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
TABLE 71 Malaysia Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
TABLE 72 Malaysia Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
TABLE 73 Malaysia Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 74 Malaysia Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 75 Rest of Asia Pacific Motion Sickness Treatment Market, 2019 - 2022, USD Million
TABLE 76 Rest of Asia Pacific Motion Sickness Treatment Market, 2023 - 2029, USD Million
TABLE 77 Rest of Asia Pacific Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 78 Rest of Asia Pacific Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
TABLE 79 Rest of Asia Pacific Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
TABLE 80 Rest of Asia Pacific Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
TABLE 81 Rest of Asia Pacific Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 82 Rest of Asia Pacific Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 83 key information – Viatris, Inc.
TABLE 84 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 85 Key Information – Amneal Pharmaceuticals, INc.
TABLE 86 Key Information – Baxter International, Inc.
TABLE 87 Key Information – Novartis AG
TABLE 88 Key Information – Abbott Laboratories
TABLE 89 Key Information – Sun Pharmaceutical Industries Ltd.
TABLE 90 Key Information – Zydus Lifesciences Ltd.
TABLE 91 Key Information – Prestige consumer healthcare inc.
TABLE 92 Key Information – WellSpring Pharmaceutical Corporation
List of Figures
FIG 1 Methodology for the research
FIG 2 Swot analysis: Abbott laboratories